K. Elgjo

4.8k total citations
160 papers, 3.8k citations indexed

About

K. Elgjo is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, K. Elgjo has authored 160 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 39 papers in Epidemiology and 27 papers in Hepatology. Recurrent topics in K. Elgjo's work include Liver Disease Diagnosis and Treatment (24 papers), Liver Diseases and Immunity (21 papers) and Microtubule and mitosis dynamics (9 papers). K. Elgjo is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Liver Diseases and Immunity (21 papers) and Microtubule and mitosis dynamics (9 papers). K. Elgjo collaborates with scholars based in Norway, India and United States. K. Elgjo's co-authors include O. Fausa, Henry Hennings, E Gjone, E. Schrumpf, Erik Schrumpf, F. Kolmannskog, S Ritland, P Brandtzæg, Stuart H. Yuspa and O. P. F. Clausen and has published in prestigious journals such as Nature, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

K. Elgjo

157 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Elgjo Norway 35 1.0k 987 972 896 598 160 3.8k
Véronique Barbu France 35 1.1k 1.1× 1.5k 1.5× 963 1.0× 1.2k 1.3× 565 0.9× 85 4.1k
F J Roll United States 18 2.1k 2.1× 1.2k 1.2× 1.3k 1.4× 829 0.9× 225 0.4× 26 4.0k
Simon C. Afford United Kingdom 36 1.9k 1.9× 1.0k 1.1× 1.1k 1.2× 1.6k 1.8× 349 0.6× 114 4.6k
Zsuzsa Schaff Hungary 34 575 0.6× 1.1k 1.2× 805 0.8× 594 0.7× 119 0.2× 154 3.4k
Katsuhiko Enomoto Japan 33 591 0.6× 2.0k 2.0× 547 0.6× 546 0.6× 168 0.3× 103 3.8k
R. Christopher Benyon United Kingdom 32 2.4k 2.4× 1.1k 1.1× 1.8k 1.9× 815 0.9× 154 0.3× 50 5.0k
Peter G. Traber United States 41 600 0.6× 2.1k 2.1× 613 0.6× 1.4k 1.6× 2.4k 4.0× 83 5.3k
Takahiro Kodama Japan 39 884 0.9× 2.4k 2.4× 1.3k 1.3× 848 0.9× 264 0.4× 176 5.8k
Keng‐Hsin Lan Taiwan 33 1.2k 1.2× 1.4k 1.4× 1.1k 1.2× 305 0.3× 517 0.9× 129 3.7k
Masayoshi Namba Japan 35 422 0.4× 2.8k 2.8× 269 0.3× 487 0.5× 594 1.0× 186 4.8k

Countries citing papers authored by K. Elgjo

Since Specialization
Citations

This map shows the geographic impact of K. Elgjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Elgjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Elgjo more than expected).

Fields of papers citing papers by K. Elgjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Elgjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Elgjo. The network helps show where K. Elgjo may publish in the future.

Co-authorship network of co-authors of K. Elgjo

This figure shows the co-authorship network connecting the top 25 collaborators of K. Elgjo. A scholar is included among the top collaborators of K. Elgjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Elgjo. K. Elgjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mancinelli, Loretta, et al.. (2009). A class of DNA-binding peptides from wheat bud causes growth inhibition, G2 cell cycle arrest and apoptosis induction in HeLa cells. Molecular Cancer. 8(1). 55–55. 12 indexed citations
2.
Eide, Nils, Per Syrdalen, David Scheie, et al.. (2001). Uveal melanomas with optic nerve extension: Report of two cases diagnosed by transvitreal biopsy, one of them with a multicentric tumour. Acta Ophthalmologica Scandinavica. 79(3). 322–325. 1 indexed citations
3.
Moum, Bjørn, Anders Ekbom, Morten H. Vatn, & K. Elgjo. (1999). Change in The Extent of Colonoscopic and Histological Involvement in Ulcerative Colitis Over Time. The American Journal of Gastroenterology. 94(6). 1564–1569. 107 indexed citations
4.
Elgjo, K., et al.. (1998). Growth-Inhibiting N-Substituted Endogenous Peptides. Progress in molecular and subcellular biology. 20. 143–159. 7 indexed citations
5.
Reichelt, Karl L., et al.. (1998). Antiproliferative Effect of the Tripeptide PyroGlu-Phe-GlyNH2on Murine Melanocytes: Transitory Delay of Cell Growthin Vitroand the Cell Cycle Specificity. Experimental Cell Research. 243(2). 367–374. 3 indexed citations
6.
Elgjo, K., et al.. (1996). Regeneration of rat corneal epithelium is delayed by the inhibitory epidermal pentapeptide (EPP). Acta Ophthalmologica Scandinavica. 74(4). 361–363. 3 indexed citations
7.
Elgjo, K., et al.. (1994). An intraocular paraganglioma?. Acta Ophthalmologica. 72(1). 138–141. 4 indexed citations
8.
Iversen, Olav Hilmar, K. Elgjo, Jan Erik Paulsen, & Karl L. Reichelt. (1993). Moderate enhancement of the promotion phase of skin tumorigenesis in hairless mice by topical pretreatment with a mitosis-inhibiting epidermal pentapeptide. Carcinogenesis. 14(12). 2537–2542. 2 indexed citations
9.
Ushmorov, Alexey, et al.. (1992). Modulation of KB and A431 cell adhesion by epidermal growth inhibitory pentapeptide. Virchows Archiv B Cell Pathology Including Molecular Pathology. 62(1). 353–356.
10.
Paulsen, Jan Erik, Kirsten Sundby Hall, Liv Endresen, et al.. (1991). The peptide pyroGlu-Gln-Gly-Ser-Asn, isolated from mouse liver, inhibits growth of rat hepatoma cells in vitro. Carcinogenesis. 12(2). 207–210. 7 indexed citations
11.
Fausa, O., Erik Schrumpf, & K. Elgjo. (1991). Relationship of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Seminars in Liver Disease. 11(1). 31–39. 212 indexed citations
12.
Jacobsen, M. B., O. Fausa, K. Elgjo, & E. Schrumpf. (1990). Hepatic Lesions in Adult Coeliac Disease. Scandinavian Journal of Gastroenterology. 25(7). 656–662. 87 indexed citations
13.
Elgjo, K. & Karl L. Reichelt. (1990). Mouse epidermal cell renewal after topical treatment with different concentrations of the epidermal peptide pyroGlu-Glu-Asp-Ser-GlyOH. Virchows Archiv B Cell Pathology Including Molecular Pathology. 59(1). 89–93. 4 indexed citations
14.
Reichelt, Karl-Ludvig, et al.. (1990). Isolation of a growth and mitosis inhibitory peptide from mouse liver. Virchows Archiv B Cell Pathology Including Molecular Pathology. 59(1). 137–142. 10 indexed citations
15.
Valnes, K, P Brandtzæg, R Stave, & K. Elgjo. (1988). Local Immune Defence in Relation to Gastritis in Billroth-II-Resected Stomachs. Scandinavian Journal of Gastroenterology. 23(10). 1217–1224. 1 indexed citations
16.
Valnes, K, P Brandtzæg, K. Elgjo, et al.. (1987). Local immunoglobulin production is different in gastritis associated with dermatitis herpetiformis and simple gastritis.. Gut. 28(12). 1589–1594. 6 indexed citations
17.
Aadland, E., E. Schrumpf, O. Fausa, et al.. (1987). Primary Sclerosing Cholangitis: A Long-Term Follow-up Study. Scandinavian Journal of Gastroenterology. 22(6). 655–664. 216 indexed citations
18.
Rognum, TO, P Brandtzæg, K. Elgjo, & O. Fausa. (1987). Heterogeneous epithelial expression of class II (HLA-DR) determinants and secretory component related to dysplasia in ulcerative colitis. British Journal of Cancer. 56(4). 419–424. 19 indexed citations
19.
Valnes, K, P Brandtzæg, K. Elgjo, & R Stave. (1986). Quantitative distribution of immunoglobulin-producing cells in gastric mucosa: relation to chronic gastritis and glandular atrophy.. Gut. 27(5). 505–514. 41 indexed citations
20.
Hennings, Henry, Edwin F. Spangler, Deborah E. Devor, et al.. (1986). Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-1 mice.. Environmental Health Perspectives. 68. 69–74. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Barbu Breakdown of academic impact, for papers by F J Roll Breakdown of academic impact, for papers by Simon C. Afford Breakdown of academic impact, for papers by Zsuzsa Schaff Breakdown of academic impact, for papers by Katsuhiko Enomoto Breakdown of academic impact, for papers by R. Christopher Benyon Breakdown of academic impact, for papers by Peter G. Traber Breakdown of academic impact, for papers by Takahiro Kodama Breakdown of academic impact, for papers by Keng‐Hsin Lan Breakdown of academic impact, for papers by Masayoshi Namba
Rankless by CCL
2026